Renvela and Medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Renvela (sevelamer carbonate) and Medrol (methylprednisolone). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Renvela and Medrol. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.



On Jul, 20, 2026

35 people who take Renvela and Medrol together, and have interactions are studied.

Renvela and Medrol drug interactions.

What are the common drug interactions of Renvela and Medrol, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Hypervolaemia (abnormally increased volume of blood)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Drug hypersensitivity
  8. Respiratory distress (difficulty in breathing)
  9. Acute hepatic failure
  10. Asthenia (weakness)

male:

  1. Chronic kidney disease
  2. Hospitalisation
  3. Pain
  4. Myeloid leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Nephropathy (damage to or disease of a kidney)
  7. Acute myocardial infarction (acute heart attack)
  8. Apathy
  9. Asthenia (weakness)
  10. Cachexia (loss of weight)

What are the common drug interactions of Renvela and Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hospitalisation
  2. Hypertension (high blood pressure)
  3. Urinary tract infection
  4. Infection
  5. Chronic kidney disease
  6. Death

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Depression
  5. Emotional distress
  6. Pain
  7. Myeloid leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts)
  8. Anaemia (lack of blood)
  9. Apathy
  10. Asthenia (weakness)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Arrhythmia (irregular heartbeat)
  5. Atrioventricular block (heart block)
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diabetic nephropathy (diabetic kidney disease)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Hypervolaemia (abnormally increased volume of blood)

60+:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  5. Lactic acidosis (low ph in body tissues)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  8. Blood pressure increased
  9. Feeling hot
  10. Nephropathy (damage to or disease of a kidney)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 28.57%
  2. Pain: 9 people, 25.71%
  3. High Blood Pressure: 9 people, 25.71%
  4. High Blood Cholesterol: 7 people, 20.00%
  5. Indigestion: 5 people, 14.29%
  6. Infection: 4 people, 11.43%
  7. Hypersensitivity: 3 people, 8.57%
  8. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 3 people, 8.57%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 8.57%
  10. Multiple Myeloma (cancer of the plasma cells): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and Medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Renvela and Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Renvela and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Medrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sevelamer carbonate and methylprednisolone (the active ingredients of Renvela and Medrol, respectively), and Renvela and Medrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: